<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04542668</url>
  </required_header>
  <id_info>
    <org_study_id>EFEX-OA-02_FINAL_Protocol_v1.2</org_study_id>
    <nct_id>NCT04542668</nct_id>
  </id_info>
  <brief_title>The Effect of Exercise on Serum Levels of Collagen and Proteoglycan in Patients With Knee Osteoarthritis</brief_title>
  <acronym>EFEX-OA-02</acronym>
  <official_title>An Open-label, Randomized, Cross-over Study to Investigate the Effect of Weight-bearing vs Non-weight-bearing Exercise and Cardiovascular Stress Without Load on Collagen and Proteoglycan in Serum and Urine in Patients With Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nordic Bioscience A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NBCD A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Nordic Bioscience A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of EFEX-OA-02 is to explore how running, cycling, exercise simulation and resting&#xD;
      acutely influence collagen and proteoglycan homeostasis in OA, as reflected by changes in&#xD;
      collagen and proteoglycan levels in urine and serum.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 8, 2020</start_date>
  <completion_date type="Actual">June 7, 2021</completion_date>
  <primary_completion_date type="Actual">June 7, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The study period will be 4 weeks. In each week, the subjects will undergo a different physical activity intervention. The order of the interventions will be randomized. The interventions will be separated by a minimum of 4 days. Inteventions: Cycling, Running, exercise-simulation with inotropy and resting.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute chances in biomarkers</measure>
    <time_frame>Acute: 0-4 hours and subacute: 24 hours</time_frame>
    <description>Serum and urine biochemical markers of joint related collagens and proteoglycan (not further specified)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Cycling as first intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cycling -&gt; Running -&gt; Inotropy -&gt; Resting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Running as first intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Running -&gt; Cycling -&gt; Inotropy -&gt; Resting</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cycling then running</intervention_name>
    <description>Ergometer cycling Treadmill running</description>
    <arm_group_label>Cycling as first intervention</arm_group_label>
    <other_name>Exercise</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Running then cycling</intervention_name>
    <description>Treadmill running Ergometer cycling</description>
    <arm_group_label>Running as first intervention</arm_group_label>
    <other_name>Exercise</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inotropy</intervention_name>
    <description>Adrenaline induced inotropy</description>
    <arm_group_label>Cycling as first intervention</arm_group_label>
    <arm_group_label>Running as first intervention</arm_group_label>
    <other_name>Exercise simulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resting</intervention_name>
    <description>Subjects must be minimally physically active</description>
    <arm_group_label>Cycling as first intervention</arm_group_label>
    <arm_group_label>Running as first intervention</arm_group_label>
    <other_name>Non-Ex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Cumulated Osteoarthritis Kellgren-Lawrence radiological grade of at least 2 in the&#xD;
             tibio-femoral joints diagnosed by screening X-ray.&#xD;
&#xD;
          2. 40 to &lt; 75 years of age at time of signing the informed consent.&#xD;
&#xD;
          3. Body weight &gt; 50 and &lt; 100 kg and BMI in the range 18.5-35 kg/m2 .&#xD;
&#xD;
          4. Male or female.&#xD;
&#xD;
          5. Able to attend all four study sessions and comply with the dietary and activity&#xD;
             restrictions.&#xD;
&#xD;
          6. Able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Medical conditions:&#xD;
&#xD;
          1. Osteoarthritis Kellgren-Lawrence radiological grade of 4 in one or both knees.&#xD;
&#xD;
          2. Cumulated osteoarthritis Kellgren-Lawrence radiological grade no higher than 1.&#xD;
&#xD;
          3. History of arthroscopy or intra-articular administration of corticosteroids or&#xD;
             hyaluronic acid into the target knee within 6 months before screening.&#xD;
&#xD;
          4. Previous arthroplasty of knee or hip.&#xD;
&#xD;
          5. Intention to have major surgery during the timeframe of the study.&#xD;
&#xD;
          6. Secondary OA related to e.g. any known trauma including cruciate ligament tears,&#xD;
             meniscus tears and cartilage damage, dysplasia, aseptic osteonecrosis, acromegaly,&#xD;
             Paget disease, Stickler syndrome, hemochromatosis, gout, chondrocalcinosis&#xD;
             (pseudogout).&#xD;
&#xD;
          7. Current treatment with beta-receptor adrenergic antagonists (beta-blockers), MAO&#xD;
             inhibitor, systemic corticosteroid treatment in doses equivalent to &gt; 10 mg&#xD;
             prednisolone per day, or vitamin K antagonists, new oral anticoagulants, fractionated&#xD;
             and non-fractionated heparin.&#xD;
&#xD;
          8. Active systemic infection.&#xD;
&#xD;
          9. Active systemic inflammatory or autoimmune disease.&#xD;
&#xD;
         10. Any sign of previous or current cardiovascular disease.&#xD;
&#xD;
         11. Not currently an active athlete or highly trained individual.&#xD;
&#xD;
        Other exclusion criteria:&#xD;
&#xD;
          1. Legal incapacity or limited legal capacity.&#xD;
&#xD;
          2. Inability to communicate or cooperate with the investigator or to comply with the&#xD;
             requirements of the entire study.&#xD;
&#xD;
          3. Categorized as being very difficult to draw blood from, as evaluated by the&#xD;
             investigator.&#xD;
&#xD;
          4. Current alcohol abuse and/or inability to refrain from intake of alcoholic beverages&#xD;
             for 24 hours prior to the study intervention.&#xD;
&#xD;
          5. Other factors, e.g. self-reported drug abuse, which in the opinion of the investigator&#xD;
             may interfere with the performance of the study.&#xD;
&#xD;
          6. Site staff, study staff members and study staff family members.&#xD;
&#xD;
          7. Other concomitant disease compromising or otherwise significantly affecting ECM&#xD;
             turnover in the opinion of the investigator.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niels Secher, MD, DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 27, 2020</study_first_submitted>
  <study_first_submitted_qc>September 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2020</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

